Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1197720220150020146
´ëÇÑÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸÁö
2022 Volume.15 No. 2 p.146 ~ p.150
Long-Term Outcome of Hemimasticatory Spasm
Rayorcid Somdattaa

Kamble Nitish
Yadav Ravi
Pal Pramod Kumar
Abstract
Objective: This study aims to identify the demographic, clinical, and therapeutic characteristics of four patients with hemimasticatory spasm (HMS) seen in our outpatient department over a period of 20 years.

Methods: We performed a retrospective chart review of four patients with HMS who visited outpatient services in the Department of Neurology from 2001 to 2020.

Results: The follow-up for all patients ranged from 2 years to 9 years. Three patients had facial or bucco-oral morphea. Two patients maintained long-term improvements in symptoms after being treated with botulinum toxin for 4?7 years, while one patient reported improvement in symptoms with treatment of carbamazepine that subsequently remitted after pregnancy.

Conclusion: This report highlights the long-term outcome of HMS in our patients. Our patients reported a significant reduction or complete resolution of symptoms after treatment, and eventually, two patients were asymptomatic while off treatment.
KEYWORD
Botulinum toxin, Spasm, Outcome, Morphea
FullTexts / Linksout information
 
Listed journal information